R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Clinical Program Manager

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA

About the Job

Requirements

  • An RN credential, bachelor's degree, or master's degree in biological sciences or a health-related field is required.
  • At least 10 years of direct Clinical Operations experience in the pharmaceutical or biotechnology industry, preferably in Clinical Operations or Clinical Research; relevant indirect experience may also qualify.
  • At least 6 years of cross-functional study management or related leadership experience in life sciences, including multiple years managing project teams.
  • Experience in oncology trials.
  • Strong working knowledge of FDA regulations, ICH guidelines, and Good Clinical Practice.
  • Proven ability to start up, manage, and close out clinical trials, including authoring clinical study and regulatory documentation and standard operating procedures.
  • Experience selecting contract research organizations or vendors and managing external resources.
  • Ability to anticipate obstacles and difficulties and proactively provide risk assessment and mitigation strategies to achieve project goals.
  • Ability to analyze operational data, maintain quality, timeliness, and fiscal responsibility, make and drive decisions, multitask, prioritize tasks, anticipate challenges, and execute goals as an interdisciplinary team member.
  • Proficiency in Microsoft Office Suite, including Outlook, Word, Excel, and PowerPoint.
  • Travel may be required, approximately 25%.

Responsibilities

  • Act as a central contact for clinical study teams and assist with execution and management of clinical trials.
  • Adhere to Clinical Standard Operating Procedures, Good Clinical Practice, and International Council for Harmonisation guidelines.
  • Provide team leadership, guidance, and oversight for management of clinical trials within timelines and designated program budgets.
  • Partner with cross-functional teams to manage, adjust, and revise project timelines and budgets as needed.
  • Analyze data health metrics and share them with stakeholders.
  • Partner with cross-functional teams and vendors to drive query resolution and data listings review to meet objectives in a timely and efficient manner.
  • Conduct risk management, contingency planning, and scenario planning.
  • Communicate project status and issues, supervise project execution, and problem-solve to ensure project team goals are met.
  • Participate in developing study-related documentation, including study protocols.
  • Contribute to selection and management of contract research organizations and vendors, including developing requests for proposals.
  • Use available tools to track, oversee, and communicate program status to stakeholders.
  • Participate in other Clinical Operations activities as appropriate.
  • Lead a larger, more complex trial with oversight from senior Clinical Operations members.
  • Lead cross-functional Clinical Study Execution Teams with minimal support.
  • Contribute to standard operating procedure development, implementation, and training.
  • Support junior team members through mentorship.

Desired Qualifications

  • Familiarity with vendor systems or portals such as electronic Trial Master File (eTMF), Electronic Data Capture (EDC), Interactive Response Technology (IRT), and Clinical Trial Management Systems (CTMS).
  • Early- and/or late-stage oncology experience is strongly preferred.
  • Knowledge of or familiarity with clinical trial operations in ex-US regions.
  • Some experience mentoring junior staff.
  • Experience with Microsoft Project and/or Smartsheet.
  • Ability to thrive in a collaborative, flexible, fast-paced environment and deploy innovative approaches and technologies.
  • Strong written and verbal communication and interpersonal skills.
  • A high sense of priority and commitment to excellence in executing deliverables.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs